Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin/B-complex vs Pregabalin in Diabetic Peripheral Neuropathic Pain
NCT01364298Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Apr 2011
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gabapentin + vitamin b complex in diabetic polyneuropathy (DPN) (2 arms), sponsored by Merck KGaA. Primary endpoint: Numeric Pain Intensity Scale at Day 84. Started Apr 2011; status: completed.
02
Drugs
gabapentin + vitamin b complex
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT01364298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364298.